Article Details
Retrieved on: 2022-06-09 08:09:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Additionally, Alexion, AstraZeneca's Rare Disease group, will present an analysis of long-term survival data from the clinical trial programme ...
Article found on: www.miragenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here